Post-marketing Registration Study of Nifekalant Hydrochloride (NIF) Injection

Clinical trial NCT03853369 · UNKNOWN

Trial details

NCT number: NCT03853369
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Status: UNKNOWN
Study type: OBSERVATIONAL

Ventricular Tachycardia Ventricular Fibrillation

Start date: 2019-02-18
Primary completion: 2019-12-30
Enrollment: 2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.